Dengju Li

机构：Shandong Provincial Hospital, Wuhan Union Hospital, Tongji Hospital, Shandong First Medical University, Huazhong University of Science and Technology · ORCID：0000-0001-7629-2642

发表论文 183 篇 · 总被引 11267 次 · h-index 20

代表论文

• Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021 (2024 · Biomarker Research · 被引 102)
• Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (2025 · Nature Cancer · 被引 55)
• A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia (2024 · Blood · 被引 18)
• Significance of targeting DNMT3A mutations in AML (2024 · Annals of Hematology · 被引 16)
• Next-generation T cell immunotherapy: overcoming exhaustion, senescence, and suppression (2025 · Frontiers in Immunology · 被引 11)
• Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis (2025 · Arthritis Research & Therapy · 被引 8)